Resources

Selected
  • COVID-19
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)
1481 results found
2022 ∙ Shahsavarinia, K. Mahmoodpoor, A. Sadeghi-Ghyassi, F. Nedayi, A. Razzaghi, A. Zehi Saadat, M. Salehi-Pourmehr, H.
Bell's Palsy and COVID-19 Vaccination: A Systematic Review
Adults Older adults COVID-19 Safety
Rating:
Critically low
2022 ∙ Angkasekwinai, N. Prawjaeng, J. Leelahavarong, P. Khuntha, S. Pheerapanyawaranun, C. Chitpim, N. Srinonprasert, V. Chokephaibulkit, K.
Binding and neutralizing antibody levels and vaccine efficacy/effectiveness compared between heterologous and homologous primary series COVID-19 vaccination: A systematic review and meta-analysis
Adults Older adults Healthcare workers COVID-19 Administration Efficacy/effectiveness
Rating:
Critically low
2022 ∙ Angeli, F. Reboldi, G. Trapasso, M. Santilli, G. Zappa, M. Verdecchia, P.
Blood Pressure Increase following COVID-19 Vaccination: A Systematic Overview and Meta-Analysis
Adults Older adults COVID-19 Safety
Rating:
Critically low
2022 ∙ Du, Y. Chen, L. Shi, Y.
Booster COVID-19 vaccination against the SARS-CoV-2 Omicron variant: a systematic review
All age groups Healthcare workers COVID-19 Efficacy/effectiveness Administration
Rating:
Critically low
2022 ∙ Lee, A. R. Y. B. Wong, S. Y. Tay, S. H.
Booster COVID-19 Vaccines for Immune-Mediated Inflammatory Disease Patients: A Systematic Review and Meta-Analysis of Efficacy and Safety
Adults Older adults Adolescents COVID-19 Safety Efficacy/effectiveness
Rating:
Low
2022 ∙ Mai, Aaron Shengting Lee, Ainsley Ryan Yan Bin Tay, Ryan Yong Kiat Shapiro, Lauren Thakkar, Astha Halmos, Balazs Grinshpun, Albert Herishanu, Yair Benjamini, Ohad Tadmor, Tamar Shroff, Rachna T. LaFleur, Bonnie J. Bhattacharya, Deepta Peng, Siyu Tey, Jeremy Lee, Soo Chin Chai, Louis Yi Ann Soon, Yu Yang Sundar, Raghav Lee, Matilda Xinwei
Booster Doses of COVID-19 Vaccines for Haematological and Solid Cancer Patients: A Systematic Review and Individual Patient Data Meta-Analysis
All age groups COVID-19 Efficacy/effectiveness
Rating:
Critically low
2022 ∙ Parmar, K. Subramanyam, S. Del Rio-Pertuz, G. Sethi, P. Argueta-Sosa, E.
Cardiac Adverse Events after Vaccination—A Systematic Review
Adults COVID-19 Smallpox Influenza Pneumococcal disease Tetanus Cholera Safety
Rating:
Critically low
2022 ∙ Samimisedeh, P. Jafari Afshar, E. Shafiabadi Hassani, N. Rastad, H.
Cardiac MRI Findings in COVID-19 Vaccine-Related Myocarditis: A Pooled Analysis of 468 Patients
All age groups COVID-19 Safety
Rating:
Critically low
2022 ∙ Chang, Y. Lv, G. Liu, C. Huang, E. Luo, B.
Cardiovascular safety of COVID-19 studies: vaccines in real-world a systematic review and meta-analysis
Adolescents Adults Older adults COVID-19 Safety
Rating:
Low
2022 ∙ Kumar, S. Shah, Z. Garfield, S.
Causes of Vaccine Hesitancy in Adults for the Influenza and COVID-19 Vaccines: A Systematic Literature Review
Adults Older adults Influenza COVID-19 Acceptance
Rating:
Not applicable
Loading...